Track topics on Twitter Track topics that are important to you
ServiceSource (NASDAQ: SREV), the digital customer journey experience company, today announced that it will release its financial results for the first quarter 2019 ended March 31, 2019 after market close on Wednesday, May 8, 2019. Management will host a conference call later that day at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) to discuss those results.
To access the call, please dial (877) 293-5486, or outside the U.S. (914) 495-8592, at least five minutes prior to the 2:30 p.m. MT start time. A live webcast of the call will also be available on the ServiceSource Investor Relations website under Events and Presentations. A replay of the webcast will also be available on the Company's Investor Relations website at http://ir.servicesource.com.
ServiceSource International, Inc. (NASDAQ: SREV) brings the world’s greatest brands closer to their customers through digitally-enabled solutions and data-driven insights that personalize and power the moments that matter. Backed by 20 years of experience, an industry-leading technology platform, a robust global footprint and a powerful suite of solutions that enhance every touchpoint along the Customer Journey Experience (CJX), we deliver impactful revenue growth for global market leaders. Operating out of eight countries with more than 3,000 sales delivery professionals speaking 45 languages, ServiceSource drives billions of dollars in client value annually. To learn more about how we help our clients more effectively find, convert, nurture, grow and retain their customers, visit www.servicesource.com.
ServiceSource®, and any ServiceSource product or service names or logos above are trademarks of ServiceSource International, Inc. All other trademarks used herein belong to their respective owners.
Investor Relations Contact for ServiceSource
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...